Prosthetic hip infection in patients with liver cirrhosis: An outcome analysis

International Journal of Infectious Diseases

Volumn 14, Issue 12, 2010, Pages

  Hsieh, Pang Hsin ^a,b   Ueng, Steve W ^a,b   Lee, Mel S ^a,b   Shih, Hsin Nung ^a,b   Huang, Kuo Chin ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Antibiotic loaded cement spacer; Liver cirrhosis; Prosthetic hip infection

Indexed keywords

ADULT; AGED; ARTHROPLASTY; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; DEBRIDEMENT; DECOMPENSATED LIVER CIRRHOSIS; DISEASE DURATION; FEMALE; HIP PROSTHESIS; HUMAN; LIVER CIRRHOSIS; MALE; OUTCOME ASSESSMENT; PROGNOSIS; PROSTHESIS INFECTION; REIMPLANTATION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ARTHROPLASTY; COHORT STUDIES; CULTURE MEDIA; DEBRIDEMENT; FEMALE; HIP PROSTHESIS; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROGNOSIS; PROSTHESIS-RELATED INFECTIONS; RECURRENCE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; TREATMENT OUTCOME;

EID: 78649632723     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2010.06.018     Document Type: Article

References (27)

1. Sung J.L. Prevention of hepatitis B and C virus infection for prevention of cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol 1997, 12:S370-S376.
2. Chedid A., Mendenhall C.L., Gartside P., French S.W., Chen T., Rabin L. Prognostic factors in alcoholic liver disease. VA Cooperative Study Group. Am J Gastroenterol 1991, 86:210-216.
3. Jackson F.C., Christophersen E.B., Peternel W.W., Kirimli B. Preoperative management of patients with liver disease. Surg Clin North Am 1968, 48:907-930.
4. Ziser A., Plevak D.J., Wiesner R.H., Rakela J., Offord K.P., Brown D.L. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology 1999, 90:42-53.
5. Hsieh P.H., Chen L.H., Lee M.S., Chen C.H., Yang W.E., Shih C.H. Hip arthroplasty in patients with cirrhosis of the liver. J Bone Joint Surg Br 2003, 85:818-821.
6. Moon Y.W., Kim Y.S., Kwon S.Y., Kim S.Y., Lim S.J., Park Y.S. Perioperative risk of hip arthroplasty in patients with cirrhotic liver disease. J Korean Med Sci 2007, 22:223-226.
7. Huo M.H., Gilbert N.F., Parvizi J. What's new in total hip arthroplasty. J Bone Joint Surg Am 2007, 89:1874-1885.
8. Teh S.H., Nagorney D.M., Stevens S.R., Offord K.P., Therneau T.M., Plevak D.J., et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology 2007, 132:1261-1269.
9. Pugh R.N., Murray-Lyon I.M., Dawson J.L., Pietroni M.C., Williams R. Transection of oesophagus for bleeding oesophageal varices. Br J Surg 1973, 60:646-649.
10. Mirra J.M., Amstutz H.C., Matos M., Gold R. The pathology of the joint tissues and its clinical relevance in prosthesis failure. Clin Orthop 1976, 117:221-240.
11. Huo T.I., Lin H.C., Lee F.Y., Huo M.C., Lee P.C., Wu J.C., et al. Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score. Liver Int 2006, 26:55-61.
12. Ferenci P., Lockwood A., Mullen K., Tarter R., Weissenborn K., Blei A.T. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002, 35:716-721.
13. Arroyo V., Gines P., Gerbes A.L., Dudley F.J., Gentilini P., Laffi G., et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996, 23:164-173.
14. Burger R.R., Basch T., Hopson C.N. Implant salvage in infected total knee arthroplasty. Clin Orthop 1991, 273:105-112.
15. Tattevin P., Cremieux A.C., Pottier P., Huten D., Carbon C. Prosthetic joint infection: when can prosthesis salvage be considered?. Clin Infect Dis 1999, 29:292-295.
16. Marculescu C.E., Berbari E.F., Hanssen A.D., Steckelberg J.M., Marmsen S.W., Mandrekar J.N., et al. Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis 2006, 42:471-478.
17. Drancourt M., Stein A., Argenson J.N., Zannier A., Curvale G., Raoult D. Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob Agents Chemother 1993, 37:1214-1218.
18. Widmer A.F., Frei R., Rajacic Z., Zimmerli W. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis 1990, 162:96-102.
19. Schwank S., Rajacic Z., Zimmerli W., Blaser J. Impact of bacterial biofilm formation on in vitro and in vivo activities of antibiotics. Antimicrob Agents Chemother 1998, 42:895-898.
20. Zimmerli W., Widmer A.F., Blatter M., Frei R., Ochsner P.E. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection Study Group. JAMA 1998, 279:1537-1541.
21. Huang K.C., Peng K.T., Li Y.Y., Tsai Y.H., Huang T.J., Hsu R.W. Modified vastus lateralis flap in treating a difficult hip infection. J Trauma 2005, 59:665-671.
22. Sanchez-Sotelo J., Berry D.J., Hanssen A.D., Cabanela M.E. Midterm to long-term followup of staged reimplantation for infected hip arthroplasty. Clin Orthop 2009, 467:219-224.
23. Hofmann A.A., Goldberg T.D., Tanner A.M., Cook T.M. Ten-year experience using an articulating antibiotic cement hip spacer for the treatment of chronically infected total hip. J Arthroplasty 2005, 20:874-879.
24. Hsieh P.H., Shih C.H., Chang Y.H., Lee M.S., Shih H.N., Yang W.E. Two-stage revision hip arthroplasty for infection: comparison between the interim use of antibiotic-loaded cement beads and a spacer prosthesis. J Bone Joint Surg Am 2004, 86:1989-1997.
25. Bolognesi M., Merkel C., Bianco S., Angeli P., Sacerdoti D., Amodio P., et al. Clinical significance of the evaluation of hepatic reticuloendothelial removal capacity in patients with cirrhosis. Hepatology 1994, 19:628-634.
26. Fiuza C., Salcedo M., Clemente G., Tellado J.M. In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease. J Infect Dis 2000, 182:526-533.
27. Schuppan D., Afdhal N.H. Liver cirrhosis. Lancet 2008, 371:838-851.